Skip to content
X-Therma, a member of the Biotechnology Innovation Organization (BIO), is making significant headway in its fight to abolish the organ transplant list. With X-Therma’s […]
A cutting-edge biotech announces world’s first subzero transatlantic organ transports Read More »
History shows that women’s healthcare has often taken a back seat. Dating back centuries—to the early days of documentation—women have been left out of
Women’s Health Week: the evolution of women’s health screening Read More »
A variety of new treatments for multiple sclerosis (MS) have been introduced over the past 20 years, and there are some promising developments in
Science ready for ‘next step’ against multiple sclerosis Read More »
X-Therma, a member of the Biotechnology Innovation Organization (BIO), recently announced significant strides towards changing the future of organ preservation and transportation. On March
X-Therma hints at what’s next: a revolution in organ transplantation and preservation Read More »
The Covid-19 pandemic undoubtedly reshaped the landscape of healthcare and vaccine development in ways we have yet to imagine. As we navigate through another
The future of pandemic defense leverages science and tech Read More »
A 70-year-old female presents to the emergency department with chest pain. Her husband of 50 years died suddenly earlier in the day. Her pain
The science behind broken heart syndrome’s health effects Read More »
Four years after the start of the pandemic, it is well known that COVID-19 is linked with thrombosis. A new report from the Centers
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes Read More »
In October 2023, Genentech announced results from the first-ever clinical trial designed exclusively to enhance the knowledge base supporting the Black and Hispanic population
Genentech Q&A: Improving MS treatment and clinical trial diversity Read More »
Multiple sclerosis (MS) has long been known as an unpredictable, debilitating, and hard-to-pin-down autoimmune disease of the central nervous system. MS affects approximately 2.8
Immunic’s bid to improve the treatment of multiple sclerosis Read More »
The U.S. is now entering its fourth season with COVID, and the new vaccination roll-out has begun, including the option of the highly anticipated
Novavax’s Choose to Protect campaign is dedicated to driving COVID vaccination Read More »
